埃尔戈他胺向KIF5A,以促进肺腺癌中的Anoikis
Bin Bao1, Xiaojun Yu1, Wujun Zheng1
1Cardiothoracic Surgery Department, The First People's Hospital of Fuyang, Hangzhou, China.
The clinical respiratory journal
|November 9, 2024
概括
素家族成员5A (KIF5A) 在肺腺癌 (LUAD) 中被上调. 用ergotamine抑制KIF5A增强了anoikis,为LUAD治疗提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 素家族成员5A (KIF5A) 与癌症进展有关.
- 肺腺癌 (LUAD) 是一个重要的全球健康问题.
研究的目的:
- 调查KIF5A在LUAD中的作用.
- 探索KIF5A在LUAD中的功能背后的分子机制.
- 为了确定LUAD的潜在治疗点.
主要方法:
- 生物信息学分析和分子实验被用来评估KIF5A在LUAD中的表达.
- 基因组丰富分析 (GSEA) 确定了KIF5A在阿诺基斯途径中的参与.
- 分子对接和CETSA选并验证了Ergotamine作为KIF5A抑制剂.
主要成果:
- 在LUAD组织和细胞中,特别是脱离的细胞中,KIF5A的调节显著上升.
- 击败KIF5A促进了LUAD细胞中的阿诺基斯.
- 埃尔戈他胺对KIF5A具有很高的亲和力,抑制其功能,并促进LUAD细胞解体.
结论:
- 埃尔戈他胺向并抑制LUAD中的KIF5A表达.
- 低调KIF5A增强了阿诺基斯,这表明KIF5A抑制是LUAD的治疗策略.
- 这项研究为针对KIF5A.的LUAD治疗提供了新的治疗途径.
相关概念视频
Adrenergic Agonists: Direct-Acting Agents
1.4K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.4K
Adrenergic Agonists: Therapeutic Uses
731
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
731
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
148
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
148
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Drugs Affecting Neurotransmitter Release or Uptake
954
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
954
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K


